Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04140825 · ClinicalTrials.gov registry record
Within-Breath Total Respiratory Input Impedance in Healthy Adult Subjects
A clinical trial, sponsored by Restech Srl.
- Completed
- Registry status
- 231
- Enrollment target
NCT04140825: Completed study, sponsored by Restech Srl.
NCT04140825 is a clinical trial that has completed, run by Restech Srl. The registered enrollment target is 231 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04140825 has completed, sponsored by Restech Srl.
- COMPLETED
- Registry status
- 231 participants
- Enrollment target
Study Summary
Assessment of lung function requires the evaluation of pulmonary function by spirometry. However, some patients (e.g. children, elderly, or diseased individuals) may have difficulty performing the related forced maximal respiratory maneuver correctly. Forced oscillation technique (FOT) is increasingly being used in clinical settings to evaluate lung function noninvasively by measuring the mechanical input impedance of the respiratory system. FOT measures lung impedance during tidal breathing, requiring minimal patient cooperation. Recently a new methodology (within breath analysis) has emerged to evaluate changes that occur in the impedance during the breathing activity. The within-breath calculation of impedance allows separating the contribution of inspiration and expiration to the measured parameters. The purpose of this study is to establish reference ranges for within breath FOT parameters and their short term variability.
Primary Outcome
The equation resulting from the multivariate regression analysis between impedance parameters assessed during the test and anthropometric measurements of age, height, weight, sex, abdominal circumference and phenotype, breathing pattern parameters
Interventions
- DEVICE Resmon PRO FULL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 231 participants |
| Start Date | 2018-10-18 |
| Est. Completion | 2022-06-28 |
What the finished NCT04140825 record still lists
NCT04140825 is an observational study that tracks outcomes without assigning an intervention. The registered 231 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Resmon PRO FULL is the first listed.
NCT04140825 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04140825 about?
NCT04140825 is a clinical study titled "Within-Breath Total Respiratory Input Impedance in Healthy Adult Subjects". Assessment of lung function requires the evaluation of pulmonary function by spirometry. However, some patients (e.g. children, elderly, or diseased individuals) may have difficulty performing the related forced maximal respiratory maneuver correctly. Forced oscillation technique (FOT) is increasing...
What is the current status of trial NCT04140825?
This trial is currently completed. The enrollment target is 231 participants. The study started on 2018-10-18. Estimated completion is 2022-06-28.
What interventions are being tested in trial NCT04140825?
The interventions under investigation include: Resmon PRO FULL (DEVICE).
Who is sponsoring clinical trial NCT04140825?
This trial is sponsored by Restech Srl, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04077099 · 231 participants · Phase 1
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
- NCT05019495 · 231 participants · NA
Optimizing Tobacco Treatment Delivery for People Living With HIV
- NCT06023589 · 231 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- NCT06734351 · 231 participants · Phase 3
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI